| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 228.13 | n/a |
| Intrinsic value (DCF) | 2.24 | n/a |
| Graham-Dodd Method | n/a | |
| Graham Formula | n/a |
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.